Gapping up
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- APP +22.7% (also increases share repurchase authorization by $1.25 bln), INFA +19.8%, FROG +18%, RS +15.4%, PEGA +14.8%, APPN +13.6%, AMWL +10.8%, SHAK +10.2%, ATUS +9.3%, CLBT +8.5%, ZBRA +7.9%, SUM +6.6%, EPAM +6.5%, PTEN +5.5%, CBRE +5.3%, ALKS +5.3%, PGRE +5.1%, TRIP +4.9%, STLA +4.7%, RPTX +4.4%, SLVM +3.9%, GEO +3.8%, AR +3.7%, MFC +3.4% (also increases dividend), KAI +3%, HUBS +2.9%, PLMR +2.9%, CROX +2.4%, ROIC +2.3%, EPRT +2.3%, WD +2.2%, NVMI +2.1%, UPWK +2%, IRDM +1.9%, EQIX +1.8%, NTST +1.8%, CRBG +1.8%, ARR +1.8% (guidance), DNOW +1.8%, HL +1.7%, AM +1.7% (also authorizes new $500 mln share repurchase program), FCPT +1.7%, OTIS +1.7%, KNF +1.6%, AWK +1.5%, LECO +1.5%, CF +1.2%, SN +1.2%, GTX +1.2%, CW +1.1%, MSA +0.9%, ORAN +0.9%
Other news:
- SOUN +83.6% (NVDA discloses stake in SOUN)
- SPWR +24.1% (secures additional capital to drive ongoing transformation)
- PLCE +20.7% (provides shareholder update)
- KALV +16.7% (pricing of a $160.1 mln public offering of common stock and pre-funded warrants)
- APLT +10.4% (interim 12-month results from the ongoing Phase 3 INSPIRE trial)
- DWAC +7.2% (announced effectiveness of Form S-4 Registration Statement for the proposed business combination with Trump Media & Technology Group)
- GRPN +4.6% (prepaid approximately $43.1 million to terminate commitments to extend further credit)
- SIRI +3.3% ( Berkshire Hathaway increases stake)
- CPA +2.4% (reports Jan traffic data)
- BKKT +1.9% (registration statement declared effective by the SEC)
- DYN +1.5% (announces upcoming presentations on trials)
- REVG +1.5% (prices secondary offering of 16.0 mln shares of common stock at $16.50 per share)
- DNA +1.3% (Ginkgo Bioworks and SaponiQx (a subsidiary of AGEN) awarded MCDC Contract to discover and manufacture next-generation vaccine adjuvants using generative molecular design)
- MESO +1% (receives Orphan-Drug Designation for Revascor from FDA)
- CI +1% (will repurchase $3.2 bln of common stock through accelerated stock repurchase agreements with Deutsche Bank AG and Bank of America N.A.)
Analyst comments:
- COIN +8.2% (upgraded to Neutral from Underweight at JP Morgan)
- INGN +5.5% (upgraded to Outperform from Mkt Perform at William Blair)
- TER +3.3% (upgraded to Neutral from Underweight at JP Morgan)
- INGR +1.8% (upgraded to Buy from Neutral at Goldman)
- APD +1.7% (upgraded to Buy from Neutral at BofA Securities)